ILC Dover Launches Innovative EZJetFlo™ Technology for Biopharmaceutical Manufacturing Processes

Transforming Biopharmaceutical Manufacturing with EZJetFlo™ Technology



ILC Dover, a notable name under Ingersoll Rand, recently introduced its cutting-edge EZJetFlo™ technology, which is set to revolutionize the way biopharmaceutical manufacturers approach powder dissolution and mixing. This innovative system aims to streamline operations, enhance consistency, and speed up the production process. For an industry continually striving for improved productivity without compromising quality, the EZJetFlo™ is a welcome advancement.

The Challenges of Powder Dissolution



In the bioprocessing realm, achieving efficient powder dissolution poses significant challenges. Issues such as incomplete wetting, agglomeration of powders, and prolonged mixing times can adversely affect batch quality and overall process efficiency. These complications hinder scalability, a critical aspect for manufacturers aiming to meet rising market demands.

EZJetFlo™ directly addresses these hurdles with its Venturi-based design, which facilitates the rapid induction of powders into a high-velocity liquid stream. This process enables immediate wetting, dispersion, and dissolution in a fully enclosed and single-use system, eliminating many of the pitfalls associated with traditional methods.

Remarkable Performance Data



Recent tests documented in a white paper titled "Enhancing Biopharmaceutical Production Through Advanced Mixing Boosting Performance with EZJetFlo™ Technology" highlighted notable improvements in powder induction and mixing efficiency on a scale of 900 liters. The following findings underscore the system's capabilities:

  • - Increased Powder Induction: When adjusting pump speeds from 61% to 71%, the feed rates for powders saw an impressive rise of approximately 25%. This correlation between flow dynamics and the Venturi's suction effectiveness is critical for enhancing productivity.
  • - Material Versatility: The system demonstrated broad compatibility with various materials, including sodium hydroxide, glucose, and starch, achieving stable feeding without clogging or operational issues.
  • - Swift Dissolution: With highly soluble substances like sodium hydroxide, rapid pH changes were observed, reflecting swift dissolution and uniform distribution throughout the system.
  • - Exceptional Mixing Efficiency: Over 99.5% of solids were effectively dissolved within just 2-3 minutes, with less than 0.5% retained particles even in more challenging formulations.

Operational and Sustainability Benefits



Beyond these performance advancements, the EZJetFlo™ technology offers considerable operational benefits, including reduced reliance on conventional tank agitation practices, lower energy consumption, and a minimized need for maintenance. Its entirely closed and single-use nature further reduces the risks of cross-contamination while adhering to current Good Manufacturing Practice (cGMP) regulations and new Annex 1 guidance.

As the demand for greater operational efficiency and flexibility continues to rise, ILC Dover's EZJetFlo™ technology stands out as a robust and scalable solution for optimizing powder handling, media, and buffer preparation workflows. This innovation not only supports biopharmaceutical manufacturers in enhancing their processes but also empowers them to deliver consistent, high-quality products that meet the ever-evolving needs of the marketplace.

For those interested in exploring this transformative technology further, ILC Dover provides detailed technical evaluations and insights through their white paper, available for download.

About ILC Dover



With over 25 years of expertise in the industry, ILC Dover has established itself as a leader in the design and production of innovative solutions for biopharmaceutical, pharmaceutical, medical device, and aerospace markets. Their commitment lies in offering custom containment solutions that address the most complex bioprocessing challenges, ultimately supporting manufacturers in delivering life-saving therapies. To learn more, visit www.ilcdover.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.